Johnston JA - Search Results

1

Timing of drotrecogin alfa (activated) initiation in treatment of severe sepsis: a database cohort study of hospital mortality, length of stay, and costs.

Ernst FR, Johnston JA, Pulgar S, He J, Ball DE, Young JK, Cooper LM. Ernst FR, et al. Among authors: johnston ja. Curr Med Res Opin. 2007 Jan;23(1):235-44. doi: 10.1185/030079906X162737. Curr Med Res Opin. 2007. PMID: 17207305

2

Managing severe sepsis: a national survey of current practices.

Durthaler JM, Ernst FR, Johnston JA. Durthaler JM, et al. Among authors: johnston ja. Am J Health Syst Pharm. 2009 Jan 1;66(1):45-53. doi: 10.2146/ajhp080067. Am J Health Syst Pharm. 2009. PMID: 19106344

3

Impact of HIV/AIDS on care and outcomes of severe sepsis.

Mrus JM, Braun L, Yi MS, Linde-Zwirble WT, Johnston JA. Mrus JM, et al. Among authors: johnston ja. Crit Care. 2005;9(6):R623-30. doi: 10.1186/cc3811. Epub 2005 Sep 27. Crit Care. 2005. PMID: 16280060 Free PMC article.

4

Determinants of mortality in patients with severe sepsis.

Johnston JA. Johnston JA. Med Decis Making. 2005 Jul-Aug;25(4):374-86. doi: 10.1177/0272989X05278933. Med Decis Making. 2005. PMID: 16061889

5

Patient-specific decision modeling to guide the use of drotrecogin alpha (activated) in patients with severe sepsis.

Schauer DP, Leonard AC, Hornung RW, Johnston JA, Eckman MH. Schauer DP, et al. Among authors: johnston ja. J Crit Care. 2008 Dec;23(4):484-92. doi: 10.1016/j.jcrc.2007.12.016. Epub 2008 Apr 18. J Crit Care. 2008. PMID: 19056011

6

Impact of different measures of comorbid disease on predicted mortality of intensive care unit patients.

Johnston JA, Wagner DP, Timmons S, Welsh D, Tsevat J, Render ML. Johnston JA, et al. Med Care. 2002 Oct;40(10):929-40. doi: 10.1097/00005650-200210000-00010. Med Care. 2002. PMID: 12395026

7

Importance of organ dysfunction in determining hospital outcomes in children.

Johnston JA, Yi MS, Britto MT, Mrus JM. Johnston JA, et al. J Pediatr. 2004 May;144(5):595-601. doi: 10.1016/j.jpeds.2004.01.045. J Pediatr. 2004. PMID: 15126992

8

Variation in outcomes in Veterans Affairs intensive care units with a computerized severity measure.

Render ML, Kim HM, Deddens J, Sivaganesin S, Welsh DE, Bickel K, Freyberg R, Timmons S, Johnston J, Connors AF Jr, Wagner D, Hofer TP. Render ML, et al. Crit Care Med. 2005 May;33(5):930-9. doi: 10.1097/01.ccm.0000162497.86229.e9. Crit Care Med. 2005. PMID: 15891316

9

Automated intensive care unit risk adjustment: results from a National Veterans Affairs study.

Render ML, Kim HM, Welsh DE, Timmons S, Johnston J, Hui S, Connors AF Jr, Wagner D, Daley J, Hofer TP; VA ICU Project (VIP) Investigators. Render ML, et al. Crit Care Med. 2003 Jun;31(6):1638-46. doi: 10.1097/01.CCM.0000055372.08235.09. Crit Care Med. 2003. PMID: 12794398

10

Analysis of the effectiveness and cost benefit of leukotriene modifiers in adults with asthma in the Ohio Medicaid population.

Heaton PC, Guo JJ, Hornung RW, Johnston JA, Jang R, Moomaw CJ, Cluxton RJ. Heaton PC, et al. Among authors: johnston ja. J Manag Care Pharm. 2006 Jan-Feb;12(1):33-42. doi: 10.18553/jmcp.2006.12.1.33. J Manag Care Pharm. 2006. PMID: 16420106 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

397 results

Search Page

Filters